Inhibition of MMP-9 suppresses the occurrence of EMT and consequently retards the tumor progression, increases the survival time, and improves the survival quality of patients, which further proves the therapeutic abilities of MMP-9 inhibitors used in thyroid cancer. This evidence concerns the gene MMP9 and thyroid gland carcinoma.